Treatment of drug-eluting stent restenosis with another drug-eluting stent: Do not fail the second time!;Tratamiento de la reestenosis de un stent liberador de fármacos con otro stent liberador de fármacos: ¡No fallar en el segundo intento!

Revista Espanola de Cardiologia

Volumn 61, Issue 11, 2008, Pages 1120-1122

  Colombo, Antonio ^a,b   Latib, Azeem ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

BRACHYTHERAPY; DRUG ELUTING STENT; EDITORIAL; HUMAN; RESTENOSIS;

EID: 55849138366     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13127841     Document Type: Editorial

References (15)

1. Byrne R, Iijima R, Mehilli J, Pache J, Schulz S, Schömig A, et al. Tratamiento de la reestenosis de stents liberadores de paclitaxel mediante implantación de stents liberadores de sirolimus: resultados angiográficos y clínicos. Rev Esp Cardiol. 2008; 61: 1134-9.
2. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, Van der Giessen WJ, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation. 2004;109:1366-70.
3. Lee CW, Park DW, Lee BK, Kim YH, Hong MK, Kim JJ, et al. Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries. Am J Cardiol. 2006;97:506-11.
4. Kastrati A, Dibra A, Mehilli J, Mayer S, Pinieck S, Pache J, et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation. 2006;113: 2293-300.
5. Lemos PA, Van Mieghem CAG, Arampatzis CA, Hoye A, Ong ATL, McFadden E, et al. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes. Circulation. 2004;109:2500-2.
6. Kim YH, Lee BK, Park DW, Park KH, Choi BR, Lee CW, et al. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis. Am J Cardiol. 2006;98:1451-4.
7. Torguson R, Sabate M, Deible R, Smith K, Chu WW, Kent KM, et al. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis. Am J Cardiol. 2006;98:1340-4.
8. Lee SS, Price MJ, Wong GB, Valencia R, Damani S, Sawhney N, et al. Early-and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failure. Am J Cardiol. 2006;98:1345-8.
9. Cosgrave J, Melzi G, Corbett S, Biondi-Zoccai GG, Babic R, Airoldi F, et al. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent. Am Heart J. 2007;153:354-9.
10. Garg S, Smith K, Torguson R, Okabe T, Slottow TL, Steinberg DH, et al. Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheter Cardiovasc Interv. 2007;70:9-14.
11. Mishkel GJ, Moore AL, Markwell S, Shelton MC, Shelton ME. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol. 2007;49:181-4.
12. Corbett SJ, Cosgrave J, Melzi G, Babic R, Biondi-Zoccai GGL, Godino C, et al. Patterns of restenosis after drug-eluting stent implantation: insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents. Eur Heart J. 2006;27:2330-7.
13. Cosgrave J, Melzi G, Biondi-Zoccai GG, Airoldi F, Chieffo A, Sangiorgi GM, et al. Drug-eluting stent restenosis the pattern predicts the outcome. J Am Coll Cardiol. 2006;47:2399-404.
14. Costa MA. Treatment of drug-eluting stent restenosis. Am Heart J. 2007;153:447-9.
15. Cowley MJ. Drug-eluting stent restenosis: incidence, predictors, mechanisms, and treatment. J Interv Cardiol. 2006;19:S47-53.